Condition: Non-small Cell Lung Cancer (NSCLC) · Stage IV · Sponsor: Swiss Cancer Institute
Unfortunately, most patients are already at a very advanced stage when they are diagnosed with lung cancer, i.e. the cancer has already spread outside the lungs forming metastases. The current standard of care therapy at this advanced stage of lung cancer includes systemic anti-cancer therapy such as chemotherapy, immunotherapy to boost the body's immune response, or targeted therapy that directly hinders tumor growth. In this study, the aim is to find out whether it is better if, after a good response to the standard therapy, the remains of main tumor and the metastases are additionally treated by surgery and/or radiation.
This description comes directly from the study's public registry record.
Gwendoline Wicki · +41 31 389 91 91 · trials@swisscancerinstitute.ch
Always discuss trial participation with your own doctor first.
| Kantonspital Aarau | Aarau, Switzerland | Recruiting |
| IOSI Ospedale Regionale di Bellinzona e Valli | Bellinzona, Switzerland | Recruiting |
| Kantonsspital Graubuenden | Chur, Switzerland | Recruiting |
| Hôpital Fribourgeois - Hôpital Cantonal | Fribourg, Switzerland | Recruiting |
| Hôpitaux Universitaires Genève HUG | Geneva, Switzerland | Recruiting |
| Luzerner Kantonsspital | Lucerne, Switzerland | Recruiting |
| Universitätsspital Zürich | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06114108